NRX Pharmaceuticals, Inc.

Q2 2025 13F Holders

Symbol
NRXP
CUSIP
629444209
Type
Equity
Class
COM NEW
Num filings
26
Total reported value, excl. options
$9.76 M
Manager Report Date Value ($000) Shares Option Type